ClinConnect ClinConnect Logo
Search / Trial NCT03060590

Roles of Uremic Toxins in Uremic Sacropenia

Launched by TUNGS' TAICHUNG METROHARBOUR HOSPITAL · Feb 17, 2017

Trial Information

Current as of June 01, 2025

Completed

Keywords

Sarcopenia, Uremic Toxins

ClinConnect Summary

Patients and Methods

This study will included 300 consecutive patients receiving maintenance hemodialysis at the outpatient dialysis center of the Tungs Taichung Metroharbour Hospital, Taichung Taiwan. Recruitment will start after approval of the Ethics Committee of our hospital. Exclusion criteria were age of \<20 and \>90 years, clinical signs of acute infection during the month preceding the inclusion, active cancer or liver disease at the time of evaluation, previous diagnosis of immunological diseases and unwillingness to participate in the study. Physician will perform a complete cha...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Both sexes aged between 20-90 years. Received stable hemodialysis at least 3 months. Written informed consent.
  • Exclusion Criteria:
  • clinical signs of acute infection during the month preceding the inclusion, active cancer or liver disease at the time of evaluation, previous diagnosis of immunological diseases and unwillingness to participate in the study.

About Tungs' Taichung Metroharbour Hospital

Tungs' Taichung Metroharbour Hospital is a leading healthcare institution in Taiwan, renowned for its commitment to advancing medical research and improving patient outcomes through innovative clinical trials. With state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals, the hospital focuses on a wide range of therapeutic areas, emphasizing patient safety and ethical standards. By fostering collaborations with academic institutions and industry partners, Tungs' Taichung Metroharbour Hospital aims to contribute significantly to the global body of medical knowledge while ensuring the highest standards of care for its patients.

Locations

Taichung, , Taiwan

Patients applied

0 patients applied

Trial Officials

Paik Seong Lim, PhD

Principal Investigator

Tungs' Taichung Metroharbour Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials